NANBIOSIS-ICTS participated in the II CSIC Conference on Major Research Infrastructures, presenting its capabilities and services for biomedical research.
Madrid, December 2025 — Just yesterday, 2 of December 2025, NANBIOSIS-ICTS participated in the II Jornada de Grandes Infraestructuras de Investigación del CSIC, a key annual event organised by the Spanish National Research Council (CSIC) at its central headquarters in Madrid. The meeting, held entirely in person, followed the successful first edition in 2024 and aimed to highlight the latest developments, strategic priorities, and services offered by Spain’s Large Scientific and Technological Infrastructures.
The event opened with an institutional welcome from José María Martell (VICYT-CSIC) in representation of Eloísa del Pino, President of CSIC. This was followed by an update on European policies for research infrastructures and a detailed overview presented by José María Martell himself, who outlined the current mapping and diagnostic status of CSIC’s technological infrastructures.
A central roundtable addressed challenges and opportunities for technological infrastructures, moderated by Javier Menéndez González (VAPC-CSIC, ESFRI Chair Office), featuring representatives from CSIC, CDTI, Helmholtz, INTA-CSIC, and CIB-CSIC. The debate highlighted the importance of collaboration, innovation, and strategic alignment between major facilities.
One of the main sessions of the programme focused on presenting several large research infrastructures in which CSIC participates. During this session, NANBIOSIS-ICTS was introduced by Gabriel Alfranca (CIBER-BBN, Communication Manager of NANBIOSIS), who presented the infrastructure’s unique capabilities, advanced biomedical services, and collaboration opportunities for researchers and companies. The session also featured presentations from the Animal Health Research Centre (CISA, INIA-CSIC), AnaEE ERIC, and eLTER, illustrating the breadth of CSIC’s involvement in national and European infrastructures.
The afternoon programme concentrated on data management and open science within major research infrastructures, under the theme “EOSC at CSIC”. Led by Carmen García (IFIC-CSIC), the panel explored strategies for data governance, FAIR principles, and the impact of open data through examples from SKA, EPOS, and Doñana ICTS (LifeWatch ERIC), sparking a vibrant debate on the future of data management and analysis, including the role and challenges of AI usage.
The conference concluded with an open debate and networking session, reinforcing the importance of cooperation between research infrastructures to strengthen Spain’s scientific competitiveness. Through its active participation, NANBIOSIS reasserted its commitment to supporting biomedical research and enabling innovation through high-quality scientific and technological services.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
